Jonathan P. Terdiman, MD

Princeton University, A.B., cum laude, 1985
Columbia University, College of Physicians and Surgeons, M.D., 1989

• 1989-1992
  Resident in Internal Medicine, University of California, San Francisco, San Francisco CA
• 1992-1993
  Fellow in Critical Care Medicine, University of California, San Francisco, San Francisco, CA
• 1993-1996
  Fellow in Gastroenterology, University of California, San Francisco, San Francisco, CA
• 1996-2000
  Staff Physician, Department of Veterans Affairs Medical Center, San Francisco, CA
• 1996-2002
  Assistant Clinical Professor of Medicine, University of California, San Francisco, San Francisco, CA
• 1996-present
  Staff Physician, University of California, San Francisco Medical Center, San Francisco, CA
• 1996-present
  Director of the Colorectal Cancer Prevention Program, UCSF, San Francisco, CA
• 1998-present
  Clinical Director, Center for Inflammatory Bowel Disease, UCSF, San Francisco, CA
• 1998-present
  Member, Cancer Center, University of California, San Francisco, San Francisco, CA
• 1998-present
  Member, Gastrointestinal Oncology Section, American Gastroenterological Society, Bethesda, MD
• 1999-present
  Member, Colorectal Cancer Initiative Team, American Cancer Society California Division, Oakland, CA
• 2000-present
  Chair, Abstract Review Committee, GI Oncology Section, AGA, Bethesda, MD
• 2001-present
  Co-Chair, Crohn's and Colitis Foundation, northern California Chapter, Medical Advisory Board
• 2002-present
  Associate Professor of Clinical Medicine, University of California, San Francisco, San Francisco, CA
• 2003-present
  Director, Gastroenterology Fellowship, University of California, San Francisco, San Francisco, CA
• 2005-present
  Member, Academy of Medical Educators, University of California, San Francisco, SF, CA

• 2000
  UCSF Medical School Class of 2002, Excellence in Small Group Instruction, recipient
• 2002
  UCSF Medical School Class of 2004, Excellence in Small Group Instruction, recipient
• 2004
  UCSF Medical School Class of 2006, Excellence in Small Group Instruction, recipient
• 2005
  Excellence in Direct Teaching, recipient, UCSF Academy of Medical Educators

• Hiramoto JS, Terdiman JP, Norton JA. Evidence-based analysis: postoperative gastric bleeding: etiology and prevention. Surg Oncol 2003;12:9-19.
• Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflammatory Bowel 2003;9:351-355.
• Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS. BRAF mutations are frequently present in sporadic colorectal cancer with methylated MLH1, but not in hereditary nonpolyposis colorectal cancer. Clinical Cancer Research 2004;10:191-5
• Truta B, Allen BA, Conrad PG, Kim YS, Berk T, Gallinger S, Bapat B, Sleisenger MH, Terdiman JP. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Familial Cancer 2003;2:95-99.
• Terdiman JP. Intestinal polyposis syndromes and hereditary colorectal cancer. In Rustgi A, Lichtenstein G, Wu G, ed. Requisites in Gastroenterology. Philadelphia: WB Saunders, 2004, 135-158.
• Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A, Wiencke JW, Terdiman JP, Waldman FM. High-resolution analysis of DNA copy number alterations in colorectal cance by array-based comparative genomic hybridization. Carcinogenesis 2004;25:1345-57
• Velayos FS, Williamson A, Lung E, Bostrom A, Weber EJ, Ostroff JW, Terdiman JP. Early predictors of severe lower gastrointestinal bleeding and adverse events: a prospective study. Clinical Gastroenterology and Hepatology 2004;2:485-490.
• Truta B, Allen BA, Conrad PG, Weinberg V, Pomponio R, Lipton LR, Guerra G, Tomlinson IMP, Kim YS, Sleisenger MH, Terdiman JP. A comparison of phenotype and genotype in adenomatous polyposis patients with and without a family history. Familial Cancer 2005;4:127-33.
• Umar A, Boland CR, Terdiman JP, Syngal S, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer and microsatellite instability. J Nat Cancer Instit 2004;96:261-8.
• Velayos FS, Allen BA, Gum J, Truta B, Kim Y, Sleisenger MH, Terdiman JP. Rate of microsatellite instability in young patients with adenomas: assessment of the Bethesda guidelines to detect HNPCC. Am J Gastroenterol 2005;100:1143-49.
• Mehta KR , Nakao K, Zuraek M, Ruan D, Bergsland EK, Venook AP, Fridlyand J, Moore DH, Jain AN, Warren RS, Terdiman JP, Waldman FM. DNA copy number alterations detected by array-based comparative genomic hybridization predict survival after hepatic resection for metastatic colorectal cancer. Clin Cancer Res 2005;11:1791-7.
• Velayos FS, Lee SH, Qiu H, Dykes S, Yiu R, Terdiman JP, Garcia-Aguilar J. The Mechanism of Microsatellite Instability Is Different in Synchronous and Metachronous Colorectal Cancer. J Gastrointest Surg. 2005 Mar 1;9:329-335.
• Velayos FS, Terdiman JP Walsh JME. Effect of 5-ASA use on colorectal cancer and dysplasia risk in ulcerative colitis: a meta-analysis. Am J Gastroenterology 2005;100:1345-53.
• Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2005 Mar 15;21(6):733-8.
• Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(4):395-9.
• Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27;293(16):1979-85.
• Vesga L, Terdiman JP, Mahadevan U. Adalibumab in pregnancy. Gut 2005;54:890.
• Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105(3):569-74.
• Terdiman JP. Colorectal cancer at a young age. Gastroenterology. 200;128(4):1067-76.
• Terdiman JP. It is time to get serious about diagnosing Lynch syndrome in the general population. Gastroenterology 2005;129:741-4.
• Young Y, Terdiman JP. Endoscopic management of familial colonic neoplasia.Gastrointest Endosc Clin N Am. 2005 Jul;15(3):549-80.
• Walsh JM, Salazar R, Terdiman JP, Gildengorin G, Perez-Stable EJ. Promoting use of colorectal cancer screening tests. Can we change physician behavior? J Gen Intern Med 2005;20:1097-101.
• Deng G, Nguyen A, Tanaka H, Matsuzaki K, Bell I, Mehta KR, Terdiman JP, Waldman FM, Kakar S, Gum J, Crawley S, Sleisenger MH, Kim YS. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int J Cancer 2006;118:2999-3005
• Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW Jr, Mayer RJ, Pasche B, Pirruccello SJ, Rajput A, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Winawer SJ. Colorectal cancer screening. J Natl Compr Canc Netw. 2006;4(4):384-420.
• Yang K, Allen B, Conrad P, Powell CB, Terdiman J, Chen LM. Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families. Fam Cancer. 2006 Aug 26
• Inadomi JM, Terdiman J. Exploring utilities and outcomes with infliximab therapy. Clin Gastroenterol Hepatol. 2006 Aug;4(8):976-8.
• Velayos FS, Varma MG, Terdiman JP. Polyposis and family cancer syndromes. In Endoscopic Oncology, ed. Faigel DO, Kochman ML. Totowa: Humana Press 2006, Chap 18:197-214.
• Terdiman JP. Ulcerative Colitis Patients with Dysplastic Polyps Should be Advised to Undergo Colectomy. Inflamm Bowel Dis. 2006 Sep;12(9):916-8.